Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs GENNEX LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB GENNEX LAB. DR. REDDYS LAB/
GENNEX LAB.
 
P/E (TTM) x 19.7 35.0 56.4% View Chart
P/BV x 4.4 4.5 98.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 DR. REDDYS LAB   GENNEX LAB.
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
GENNEX LAB.
Mar-23
DR. REDDYS LAB/
GENNEX LAB.
5-Yr Chart
Click to enlarge
High Rs4,6569 51,164.3%   
Low Rs3,7885 78,743.2%   
Sales per share (Unadj.) Rs1,481.43.4 44,090.7%  
Earnings per share (Unadj.) Rs270.70.3 97,153.8%  
Cash flow per share (Unadj.) Rs345.70.3 104,572.5%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.64.5 30,547.9%  
Shares outstanding (eoy) m166.53176.64 94.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.82.1 137.7%   
Avg P/E ratio x15.625.0 62.5%  
P/CF ratio (eoy) x12.221.0 58.0%  
Price / Book Value ratio x3.01.5 198.7%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,0391,229 57,224.9%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46679 59,026.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697593 41,567.2%  
Other income Rs m10,55540 26,701.2%   
Total revenues Rs m257,252633 40,638.2%   
Gross profit Rs m63,86047 136,075.0%  
Depreciation Rs m12,5029 136,039.2%   
Interest Rs m1,42814 10,546.5%   
Profit before tax Rs m60,48564 94,908.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,41215 106,143.3%   
Profit after tax Rs m45,07349 91,593.2%  
Gross profit margin %25.97.9 327.4%  
Effective tax rate %25.522.8 111.8%   
Net profit margin %18.38.3 220.4%  
BALANCE SHEET DATA
Current assets Rs m203,161487 41,731.4%   
Current liabilities Rs m85,721295 29,045.2%   
Net working cap to sales %47.632.3 147.4%  
Current ratio x2.41.6 143.7%  
Inventory Days Days794 1,959.7%  
Debtors Days Days10757,912,589 0.0%  
Net fixed assets Rs m112,638835 13,490.2%   
Share capital Rs m833180 462.3%   
"Free" reserves Rs m230,571623 36,991.4%   
Net worth Rs m231,404804 28,799.5%   
Long term debt Rs m1,278163 784.6%   
Total assets Rs m315,7991,322 23,891.8%  
Interest coverage x43.45.7 759.7%   
Debt to equity ratio x00.2 2.7%  
Sales to assets ratio x0.80.4 174.0%   
Return on assets %14.74.7 310.2%  
Return on equity %19.56.1 318.1%  
Return on capital %26.68.0 332.8%  
Exports to sales %52.242.1 123.9%   
Imports to sales %16.813.6 123.7%   
Exports (fob) Rs m128,803250 51,494.4%   
Imports (cif) Rs m41,48481 51,437.1%   
Fx inflow Rs m128,803250 51,494.4%   
Fx outflow Rs m41,48486 48,064.0%   
Net fx Rs m87,319164 53,301.8%   
CASH FLOW
From Operations Rs m58,875237 24,867.0%  
From Investments Rs m-41,373-383 10,794.2%  
From Financial Activity Rs m-26,861210 -12,770.9%  
Net Cashflow Rs m-9,07364 -14,218.8%  

Share Holding

Indian Promoters % 26.7 23.6 112.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.3 0.0 -  
FIIs % 28.6 0.0 -  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 76.4 75.9%  
Shareholders   257,794 69,723 369.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs GENNEX LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs GENNEX LABORATORIES Share Price Performance

Period Dr. Reddys GENNEX LABORATORIES S&P BSE HEALTHCARE
1-Day 1.78% 1.35% 1.18%
1-Month -4.23% -13.90% -0.75%
1-Year 35.93% 189.91% 61.82%
3-Year CAGR 10.85% 62.78% 18.16%
5-Year CAGR 17.77% 40.09% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the GENNEX LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of GENNEX LABORATORIES the stake stands at 23.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of GENNEX LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

GENNEX LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of GENNEX LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.